Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study

Alice Y Chang, Colby Ayers, Abu Minhajuddin, Tulika Jain, Pamela Nurenberg, James A. De Lemos, Robert A. Wild, Richard J. Auchus

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objective Polycystic ovarian syndrome (PCOS), the most common endocrinopathy of young women, is characterized by androgen excess and is frequently associated with cardiovascular risk factors. However, it is unclear whether PCOS is a risk factor for atherosclerosis. We sought to determine in a multiethnic population-based sample whether women with PCOS have greater measures of subclinical atherosclerosis than women without PCOS. Design Cross-sectional study of a nested cohort from the Dallas Heart Study (2000-2002). Participants Women between the ages of 35 and 49 (n = 827). PCOS was defined by Rotterdam criteria. The normal control group had regular menses, total testosterone <2·78 nmol/l, no signs of hirsutism and no polycystic ovarian morphology by magnetic resonance imaging (MRI). Measurements Subclinical atherosclerosis defined as coronary artery calcium (CAC) by computed tomography and abdominal aortic plaque by MRI. Results The prevalence of PCOS in Dallas County was 19·6% (n = 144), and 8·0% (n = 56) had both oligomenorrhea and hyperandrogenism. Women with PCOS had higher body mass index, blood pressure, insulin and leptin than regularly cycling controls. Despite a greater prevalence of cardiovascular risk factors, women with PCOS did not have a greater prevalence of CAC > 10 Agatston units (PCOS 5%, controls 6·3%, P = 0·74) or abdominal aortic plaque (PCOS 25·8%, controls 34·4%, P = 0·13) than controls. Conclusions In a large, multiethnic, population-based sample of premenopausal women, PCOS, defined by Rotterdam criteria, was not associated with a higher prevalence of coronary artery calcium or abdominal aortic plaque.

Original languageEnglish (US)
Pages (from-to)89-96
Number of pages8
JournalClinical Endocrinology
Volume74
Issue number1
DOIs
StatePublished - Jan 2011
Externally publishedYes

Fingerprint

Polycystic Ovary Syndrome
Atherosclerosis
Menstruation
Population
Androgens
Testosterone
Coronary Vessels
Cross-Sectional Studies
Calcium
Control Groups

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study. / Chang, Alice Y; Ayers, Colby; Minhajuddin, Abu; Jain, Tulika; Nurenberg, Pamela; De Lemos, James A.; Wild, Robert A.; Auchus, Richard J.

In: Clinical Endocrinology, Vol. 74, No. 1, 01.2011, p. 89-96.

Research output: Contribution to journalArticle

Chang, Alice Y ; Ayers, Colby ; Minhajuddin, Abu ; Jain, Tulika ; Nurenberg, Pamela ; De Lemos, James A. ; Wild, Robert A. ; Auchus, Richard J. / Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study. In: Clinical Endocrinology. 2011 ; Vol. 74, No. 1. pp. 89-96.
@article{c4bbed3224fa45b2be0be36b4dfda90e,
title = "Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study",
abstract = "Objective Polycystic ovarian syndrome (PCOS), the most common endocrinopathy of young women, is characterized by androgen excess and is frequently associated with cardiovascular risk factors. However, it is unclear whether PCOS is a risk factor for atherosclerosis. We sought to determine in a multiethnic population-based sample whether women with PCOS have greater measures of subclinical atherosclerosis than women without PCOS. Design Cross-sectional study of a nested cohort from the Dallas Heart Study (2000-2002). Participants Women between the ages of 35 and 49 (n = 827). PCOS was defined by Rotterdam criteria. The normal control group had regular menses, total testosterone <2·78 nmol/l, no signs of hirsutism and no polycystic ovarian morphology by magnetic resonance imaging (MRI). Measurements Subclinical atherosclerosis defined as coronary artery calcium (CAC) by computed tomography and abdominal aortic plaque by MRI. Results The prevalence of PCOS in Dallas County was 19·6{\%} (n = 144), and 8·0{\%} (n = 56) had both oligomenorrhea and hyperandrogenism. Women with PCOS had higher body mass index, blood pressure, insulin and leptin than regularly cycling controls. Despite a greater prevalence of cardiovascular risk factors, women with PCOS did not have a greater prevalence of CAC > 10 Agatston units (PCOS 5{\%}, controls 6·3{\%}, P = 0·74) or abdominal aortic plaque (PCOS 25·8{\%}, controls 34·4{\%}, P = 0·13) than controls. Conclusions In a large, multiethnic, population-based sample of premenopausal women, PCOS, defined by Rotterdam criteria, was not associated with a higher prevalence of coronary artery calcium or abdominal aortic plaque.",
author = "Chang, {Alice Y} and Colby Ayers and Abu Minhajuddin and Tulika Jain and Pamela Nurenberg and {De Lemos}, {James A.} and Wild, {Robert A.} and Auchus, {Richard J.}",
year = "2011",
month = "1",
doi = "10.1111/j.1365-2265.2010.03907.x",
language = "English (US)",
volume = "74",
pages = "89--96",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study

AU - Chang, Alice Y

AU - Ayers, Colby

AU - Minhajuddin, Abu

AU - Jain, Tulika

AU - Nurenberg, Pamela

AU - De Lemos, James A.

AU - Wild, Robert A.

AU - Auchus, Richard J.

PY - 2011/1

Y1 - 2011/1

N2 - Objective Polycystic ovarian syndrome (PCOS), the most common endocrinopathy of young women, is characterized by androgen excess and is frequently associated with cardiovascular risk factors. However, it is unclear whether PCOS is a risk factor for atherosclerosis. We sought to determine in a multiethnic population-based sample whether women with PCOS have greater measures of subclinical atherosclerosis than women without PCOS. Design Cross-sectional study of a nested cohort from the Dallas Heart Study (2000-2002). Participants Women between the ages of 35 and 49 (n = 827). PCOS was defined by Rotterdam criteria. The normal control group had regular menses, total testosterone <2·78 nmol/l, no signs of hirsutism and no polycystic ovarian morphology by magnetic resonance imaging (MRI). Measurements Subclinical atherosclerosis defined as coronary artery calcium (CAC) by computed tomography and abdominal aortic plaque by MRI. Results The prevalence of PCOS in Dallas County was 19·6% (n = 144), and 8·0% (n = 56) had both oligomenorrhea and hyperandrogenism. Women with PCOS had higher body mass index, blood pressure, insulin and leptin than regularly cycling controls. Despite a greater prevalence of cardiovascular risk factors, women with PCOS did not have a greater prevalence of CAC > 10 Agatston units (PCOS 5%, controls 6·3%, P = 0·74) or abdominal aortic plaque (PCOS 25·8%, controls 34·4%, P = 0·13) than controls. Conclusions In a large, multiethnic, population-based sample of premenopausal women, PCOS, defined by Rotterdam criteria, was not associated with a higher prevalence of coronary artery calcium or abdominal aortic plaque.

AB - Objective Polycystic ovarian syndrome (PCOS), the most common endocrinopathy of young women, is characterized by androgen excess and is frequently associated with cardiovascular risk factors. However, it is unclear whether PCOS is a risk factor for atherosclerosis. We sought to determine in a multiethnic population-based sample whether women with PCOS have greater measures of subclinical atherosclerosis than women without PCOS. Design Cross-sectional study of a nested cohort from the Dallas Heart Study (2000-2002). Participants Women between the ages of 35 and 49 (n = 827). PCOS was defined by Rotterdam criteria. The normal control group had regular menses, total testosterone <2·78 nmol/l, no signs of hirsutism and no polycystic ovarian morphology by magnetic resonance imaging (MRI). Measurements Subclinical atherosclerosis defined as coronary artery calcium (CAC) by computed tomography and abdominal aortic plaque by MRI. Results The prevalence of PCOS in Dallas County was 19·6% (n = 144), and 8·0% (n = 56) had both oligomenorrhea and hyperandrogenism. Women with PCOS had higher body mass index, blood pressure, insulin and leptin than regularly cycling controls. Despite a greater prevalence of cardiovascular risk factors, women with PCOS did not have a greater prevalence of CAC > 10 Agatston units (PCOS 5%, controls 6·3%, P = 0·74) or abdominal aortic plaque (PCOS 25·8%, controls 34·4%, P = 0·13) than controls. Conclusions In a large, multiethnic, population-based sample of premenopausal women, PCOS, defined by Rotterdam criteria, was not associated with a higher prevalence of coronary artery calcium or abdominal aortic plaque.

UR - http://www.scopus.com/inward/record.url?scp=78650323818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650323818&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2265.2010.03907.x

DO - 10.1111/j.1365-2265.2010.03907.x

M3 - Article

C2 - 21044112

AN - SCOPUS:78650323818

VL - 74

SP - 89

EP - 96

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 1

ER -